DeborahEMeyersMDFRACP FACC

PubMed

• 31 citations
  Addition of Supervised Exercise Training to a Post-Hospital Disease Management Program for Patients Recently Hospitalized With Acute Heart Failure: The EJECTION-HF Ran...
  Alison M. Mudge, Charles Denaro, Adam C. Scott, Deborah E. Meyers, Julie Adsett, Robert Mullins, Jessica Suna, John Atherton, Thomas H. Marwick, Paul Anthony Scuffham,...> ;JACC. Heart Failure. 2018 Feb 1
• 38 citations
  End-of-Life Decisions and Palliative Care in Advanced Heart Failure.
  Deborah E. Meyers, Sarah J. Goodlin> ;The Canadian Journal of Cardiology. 2016 Sep 1
• 31 citations
  Protocol‐Driven Allied Health Post‐Discharge Transition Clinic to Reduce Hospital Readmissions in Heart Failure
  Erin K. Donaho, Andrea C. Hall, Jennifer A. Gass, MacArthur A. Elayda, Vei-Vei Lee, Shreda Paire, Deborah E. Meyers> ;Journal of the American Heart Association. 2015 Dec 22
• 13 citations
  Benefits and Challenges of Early Introduction of Left Ventricular Assist Device Placement: A Patient-Centered Perspective∗
  Courtenay R. Bruce, Jennifer Blumenthal-Barby, Deborah E. Meyers> ;Journal of the American College of Cardiology. 2015 Oct 20
• 31 citations
  Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study
  Ruben Hernandez, Steve K. Singh, Dale T. Hoang, Syed W. Ali, MacArthur A. Elayda, Hari R. Mallidi, O.H. Frazier, Deborah E. Meyers> ;Texas Heart Institute Journal. 2015 Oct 1
• 5 citations
  Trauma in patients with continuous-flow left ventricular assist devices.
  Sinan H. Sarsam, Deborah E. Meyers, Andrew B. Civitello, Enoch E. Agunanne, Peggy Odegaard, William E. Cohn, O.H. Frazier> ;The American Journal of Cardiology. 2013 Nov 1
• 17 citations
  Fatal Cardiac and Renal Allograft Rejection With Lenalidomide Therapy for Light-Chain Amyloidosis
  Deborah E. Meyers, B. Adu-Gyamfi, Ana Maria Segura, L M Buja, Hari R. Mallidi, O.H. Frazier, Lawrence Rice> ;American Journal of Transplantation. 2013 Oct 1
• 28 citations
  Missense mutations in FBN1 exons 41 and 42 cause Weill-Marchesani syndrome with thoracic aortic disease and Marfan syndrome.
  Alana C. Cecchi, Naomi Ogawa, Hugo R. Martinez, Alicia A. Carlson, Yuxin Fan, Daniel J. Penny, Dongchuan Guo, Steven B Eisenberg, Hazim J. Safi, Anthony L. Estrera, Ri...> ;American Journal of Medical Genetics. Part A. 2013 Sep 1
• 141 citations
  Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.
  Deborah E. Meyers, Haseeb Ilias Basha, Mary Kay Koenig> ;Texas Heart Institute Journal. 2013 Jan 1
• 4 citations
  Cardiac manifestations of mitochondrial disorders.
  Deborah E. Meyers, Haseeb Ilias Basha, Mary Kay Koenig> ;Texas Heart Institute Journal. 2013 Jan 1
• 2 citations
  Ventricular arrhythmias and acute left ventricular dysfunction as a primary and life-threatening manifestation of a mitochondrial crisis: A novel management strategy
  Khashayar K. Vahdat, Haseeb Ilias-Basha, Poyee P. Tung, Nada B. Memon, Andrea C. Hall, Mary Kay Koenig, Deborah E. Meyers> ;Journal of Cardiology Cases. 2012 Aug 1
• 23 citations
  Exercise training in recently hospitalized heart failure patients enrolled in a disease management programme: design of the EJECTION-HF randomized controlled trial
  Alison M. Mudge, Charles Denaro, Adam C. Scott, John Atherton, Deborah E. Meyers, Thomas H. Marwick, Julie Adsett, Robert Mullins, Jessica Suna, Paul Anthony Scuffham,...> ;European Journal of Heart Failure. 2011 Dec 1
• 61 citations
  Arg389Gly-β1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic t...
  Lu Chen, Deborah E. Meyers, George Javorsky, Darryl J. Burstow, Pakorn Lolekha, Margaret Lucas, A Semmler, Santiyagu M. Savarimuthu, Kwun M. Fong, Ian A. Yang, John At...> ;Pharmacogenetics and Genomics. 2007 Nov 1
• 4 citations
  The role of growth hormone replacement in a growth hormone deficient patient with underlying cardiomyopathy and severe congestive heart failure
  Deborah Meyers, Jo Maddicks-Law, David Seaton, Andrew J. Galbraith, Ross C. Cuneo> ;The Journal of Heart and Lung Transplantation. 2005 Jan 1
• 21 citations
  Controversies Regarding the Effects of Growth Hormone on the Heart
  Deborah Meyers, Ross C. Cuneo> ;Mayo Clinic Proceedings. 2003 Dec 1
• Join now to see all

Journal Articles

• Protocol-Driven Allied Health Post-Discharge Transition Clinic to Reduce Hospital Readmissions in Heart Failure  
  Donaho EK, Hall AC, Gass JA, Elayda MA, Lee VV, Paire S, Meyers DE, J Am Heart Assoc, 1/1/2015
• Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large SingleCenter Study  
  Hernandez RE, Singh SK, Hoang DT, Ali SW, Elayda MA, Mallidi HR, Frazier OH, Meyers DE, Tex Heart Inst J, 1/1/2015
• Trauma in patients with continuous-flow left ventricular assist devices  
  Sarsam SH, Meyers DE, Civatello AB, Aguanne EE, Odegaard P, Cohen WE, Frazier OH, Am J Cardiol, 1/1/2013
• Missense mutations in FBN1 exons 41 and 42 cause Weill-Marchesani Syndrome with thoracic aortic disease and Marfan Syndrome  
  Ogawa N, Martinez HR, Cecchi A, Carlson A, Fang Y, Dong-chuan G, Safi H, Estrera A, Meyers DE, Milewicz DM, Am J Med Genet A, 1/1/2013
• Fatal cardiac and renal allograft rejection with lenalidomide therapy for light chain amyloidosis  
  Meyers DE, Adu-Gyamfi B, Segura AM, Buja LM, Mallidi HR, Frazier OH, Rice L, Am J Transpl, 1/1/2013
• Cardiac Manifestation of mitochondrial disorders  
  Meyers DE, Basha HI, Koenig MK, Tex Heart Inst J, 1/1/2013
• Mitochondrial Cardiomyopathy: Pathophysiology, diagnosis and management  
  Meyers DE, Basha HI, Koenig MK, Tex Heart Inst J, 1/1/2013
• Ventricular arrhythmias and acute left ventricular dysfunction as a primary and life-threatening manifestation of a mitochondrial crisis: a novel management strategy  
  Vhadat KK, Ilias-Basha H, Tung PP, Memon NB, Hall AC, Meyers DE, J Card Cases, 1/1/2012
• Exercise training in recently hospitalized heart failure patients enrolled in a disease management program: design of the EJECTION-HF randomized controlled trial  
  Mudge AM, Denaro CP, Scott AC, Atherton JJ, Meyers DE, Marwick TH, Adsett JA, Mullins RW, Suna JM, Scuffham PA, O'Rourke PK, Eur J Heart, Fail, 1/1/2011
• Medical therapies for chronic management of cardiomyopathies and congestive heart failure  
  Meyers DE, Curr Cardiovasc Risk Rep, 1/1/2009
• A prospective, multicenter trial of the VentraAssist left ventricular assist device for bridge to transplant: safety and efficacy  
  Esmore D, Kaye D, Spratt P, Larbalestier R, Ruygrock P, Tsui S, Meyers D, Fiane AE, Woodard J, J Heart and Lung Transplant, 1/1/2008
• VentrAssist left ventricular assist device: clinical trial results and Clinical Development Plan update  
  Esmore D, Spratt P, Larbalestier R, Tsui S, Fiane A, Ruygrok P, Meyers D, Woodard J, Eur J Cardiothorac Surg, 1/1/2007
• Resolution of protein losing enteropathy after successful heart transplantation in an adult patient with arrythmogenic right ventricular cardiomyopathy  
  Korczyk D, Clark P, Crawford D, Maddicks-Law-J, Javorsky G, Meyers DE, J Heart Lung Transplant, 1/1/2007
• Arg389Gly-beta1 determines improvement in left ventricular systolic function in non-ischemic cardiomyopathy patients with heart failure after chronic treatment with ca...  
  Chen L, Meyers DE, Javorsky G, Burstow D, Lolekha P, Lucas M, Semmler AB, Santiyagu SM, Fong KM, Yang I, Atherton J, Galbraith AJ, Parsonage WA, Molenaar P, Pharmacogenet Genomics, 1/1/2007
• The Role of growth hormone replacement in a growth hormone deficient patient with underlying cardiomyopathy and severe heart failure  
  Meyers DE, Maddicks-Law J, Seaton DM, Galbraith AJ, Cuneo RC, J Heart Lung Transplant, 1/1/2005
• Clinical utility of rapid prescreening magnetic resonance angiography of peripheral vascular disease prior to cardiac catheterization  
  Rogers JH, Caruthers SD, Williams T, Rosa Lin SJ, Meyers D, Lanza GM, Kovacs S, Lasala JM, Wickline SA, J Cardiovasc Magn Reson, 1/1/2004
• Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure  
  Russell F, Meyers D, Galbraith AJ, Bett N, Toth I, Kearns P, Molenaar P, Am J Physiol Heart Circ Physiol, 1/1/2003
• Controversies regarding the effects of growth hormone in the heart  
  Meyers DE, Cuneo RC, Mayo Clin Proc, 1/1/2003
• Join now to see all

Books/Book Chapters

• Cardiovascular Medicine 
  Chapter: Diagnosis and Management of Ischemic Cardiomyopathy 
  Meyers, DE & Bogaev REditors: Willerson, Cohn, Wellens, Holmes.Springer PressEdition 4th,

Abstracts/Posters

• Ventricular Fibrillation Storm: A Unique Presenting Feature of Mitochondria Crisis
  Mukerji, S, Memon, S, Koenig, MK, Meyers, D, Memon, N, Heart Rhythm Society Society Scientific Sessions, Boston, MA, 1/1/2012
• Multidisciplinary heart failure discharge protocol decreases 30 day readmission.
  Hall A, Donaho E, Gass J, Meyers D, Heart Failure Society of America Annual Meeting, Boston, MA, 1/1/2012
• Ventricular Fibrillation Storm: A Unique Presenting Feature of Mitochondria Crisis
  Mukerji S, Memon S, Koenig MK, Meyers D, Memon N, Cardiostim Conference, Nice, France, 1/1/2012
• Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG 389-b1-adrenergic receptors.
  Chen L, Meyers D, Javorsky G, Burstow D, Lolekha P, Lucas M, Semmler A, Savarimuthu, Fong K, Yang I, Atherton J, Galbraith A, Parsonage W, Molenaar P, CSANZ, 1/1/2007
• Three year cumulative experience with the Ventrassist third generation left ventricular assist System.
  D. Esmore, R. Larbalestier, P. Spratt, S. Tsui, P. Rugrok, D. Meyers, A. Fiane, J. Woodward, Heart Failure Society of America Annual Meeting; EACTS, 1/1/2006
• Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARg 389-compared to Gly 389-beta1-adrenergic receptors
  L.Chen, D Meyers, G Javorsky, D Burstow, P Lolekha, M Lucas, A Semmier, S Semmler, S Savarimthu, K Fong, I Yang, A Galbraith W Parsonage P Molenaar, American Heart Association Meeting, 1/1/2006
• Induction therapy with basiliximab in orthotopic heart transplantation.
  Meyers DE, Mullaney DV, Gray SV, Immunology and Cell Biology, 1/1/2003
• Elevated plasma levels of urotensinII peptide(s) in patients with congestive heart failure.
  Russell FD, Meyers D, Galbraith AJ, Bett N,& Molenaar P, Proceedings of ASCEPT, 1/1/2001
• Photochemical chemical reactivity to EDA complexes of furocoumarins.
  Jenkins Y, Gallagher KA, Meyers DE, Ruiz DA, Otsuki T, Third National Conference-Undergraduate Research; UCLA Undergraduate Research Conference, Southern California section of the American Chemical Society, Trinity University, San Antonio, 1/27/1989
• Join now to see all

Lectures

• Therapies for Advanced Heart Failure: Selecting Patients for LVADs 
  Los Palmas Medical Center, El Paso, TX - 1/26/2015
• Medical Decision Making: Art and Science 
  Johns Hopkins University, School of Nursing, Baltimore, MD - 1/10/2015
• Integrating Advanced Care Planning Into Decisions about DT LVAD 
  Orlando, FL - 1/8/2015
• Exercise Training in Heart Failure 
  Trondheim, Norway - 1/6/2015
• Medical Decision Making and Advanced Heart Failure 
  University of Washington, Seattle, WA - 1/21/2014
• Palliative Care and Advanced Heart Failure “Never say Die” 
  Las Vegas, NV - 1/13/2014
• Behavioral Economics and Assessing Risk 
  University of Miami - 1/4/2014
• Guidelines are Best When They Guide, Not Direct 
  1/19/2013
• Managing Risk in Heart Disease 
  Mount Horib Missionary Baptist Church - 1/17/2013
• Go Red and Go Right Now-Women and Heart Disease 
  Elnita McLain Center - 1/15/2013
• Readmissions after Left Ventricular Assist Devices 
  Texas Heart Institute - 1/10/2013
• Advances in the Medical Treatment of Heart Failure 
  Texas Heart Institute - 1/7/2013
• Heart Failure, Assessing Risk & the Art & Absurdity of Decision Making 
  MD Anderson - 1/20/2012
• Behavioral Economics & Medical Decision Making 
  1/13/2012
• Why Cardiologists Never Say Die 
  MD Anderson - 1/7/2012
• New In Heart Failure 2012 
  Texas Heart Institute - 1/7/2012
• Aortic Dissection 
  Houston, TX - 1/9/2011
• Heart Failure, Risk and Decision Making 
  Houston, TX - 1/3/2011
• Heart Failure: A Comprehensive Approach 
  Houston, TX - 1/2/2011
• Marfan Syndrome and Congestive Heart Failure 
  Houston, TX - 1/26/2010
• Overview of contemporary management strategies for ADHF 
  University of Texas - 1/18/2010
• Why does a vascular surgeon need a heart failure doctor? 
  1/27/2009
• Decompensated Heart Failure: When do you consider which therapy? 
  University of Texas - 1/23/2009
• Heart Failure in the New Millenium 
  1/15/2009
• Refractory Heart Failure 
  1/29/2008
• Join now to see all